AbbVie says multiple parties vying for assets related to Allergan deal approval Medical Dialogues Bureau4 Nov 2019 3:30 AM GMTAbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
Allergan shareholders okays USD 63 billion AbbVie acquisition Medical Dialogues Bureau15 Oct 2019 4:00 AM GMTUnder the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
Everstone-backed Everlife names Raman Gandotra as new CEO Medical Dialogues Bureau15 Sep 2019 3:30 AM GMTPrior to joining Everlife, Raman Gandotra was leading the India and South-East Asia business of Smith & Nephew, Baxter and Allergan.New Delhi:...
Allergan, Endo agree to USD 15 million settlement in major opioid case Medical Dialogues Bureau24 Aug 2019 3:30 AM GMTAllergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 4:06 AM GMTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Allergan announces worldwide recall of textured breast implant tied to rare cancer Medical Dialogues Bureau26 July 2019 3:45 AM GMTThe U.S. Food and Drug Administration said it called for the removal after new information showed Allergan Inc's Biocell breast implants account for a...
Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 4:30 AM GMTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution Farhat Nasim15 April 2019 4:35 AM GMTBimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
USFDA accepts Allergan license applications to expand Botox label Farhat Nasim11 March 2019 4:00 AM GMT"The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
Allergan depression drug fails trial, loses over Rs 100 crore expected sales Farhat Nasim8 March 2019 3:30 AM GMTStanicky said the data was the most anticipated release of the year and likely means that Allergan will lose what had been expected to be a $1 billion...
Health Canada places restrictions on Allergan Fibroid treatment Esmya Farhat Nasim13 Jan 2019 3:30 AM GMTThe drug is sold in Europe by Hungarian drugmaker Richter. Richter has said it considered Esmya to be a safe and effective form of treatment.Canada:...
Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court Medical Dialogues Bureau15 Nov 2018 6:12 AM GMTThe expiry of the basic patent on Lyrica five years ago had allowed generic drugmakers to launch cut-price versions of Pfizer's medicine, which...
